Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ZP-9830 by Zealand Pharma for Chronic Inflammation: Likelihood of Approval
ZP-9830 is under clinical development by Zealand Pharma and currently in Phase I for Chronic Inflammation. According to GlobalData, Phase...